Zan Liu
23 Postal Street
Harbin, 150000, China
Harbin, 150000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A candidate prognostic biomarker: TFEB inhibits tumor progression via elevating CDKN1A in bladder cancer.
Journal: International immunopharmacology
Published: April 26, 2023
Properties of flavonoids in the treatment of bladder cancer (Review).
Journal: Experimental and therapeutic medicine
Published: June 09, 2022
LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.
Journal: Journal of clinical laboratory analysis
Published: May 17, 2022
Feedback activation of GATA1/miR-885-5p/PLIN3 pathway decreases sunitinib sensitivity in clear cell renal cell carcinoma.
Journal: Cell cycle (Georgetown, Tex.)
Published: August 14, 2020
Novel circRNA_0071196/miRNA‑19b‑3p/CIT axis is associated with proliferation and migration of bladder cancer.
Journal: International journal of oncology
Published: October 14, 2019
Down-regulation of CIT can inhibit the growth of human bladder cancer cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 15, 2019
Evaluation of the improved tubeless cutaneous ureterostomy technique following radical cystectomy in cases of invasive bladder cancer complicated by peritoneal metastasis.
Journal: Oncology letters
Published: November 02, 2015
Downregulation of long non-coding RNA TRIM52-AS1 functions as a tumor suppressor in renal cell carcinoma.
Journal: Molecular medicine reports
Published: March 27, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026